BTB Real Estate Investment Trust (BTB.UN) Price Target Raised to C$4.65

Share on StockTwits

BTB Real Estate Investment Trust (TSE:BTB.UN) had its price target boosted by analysts at National Bank Financial from C$4.50 to C$4.65 in a research note issued on Thursday. The firm presently has a “sector perform” rating on the real estate investment trust’s stock. National Bank Financial’s target price suggests a potential downside of 2.72% from the company’s current price.

Shares of BTB.UN opened at C$4.78 on Thursday. BTB Real Estate Investment Trust has a twelve month low of C$4.29 and a twelve month high of C$4.93.

BTB Real Estate Investment Trust Company Profile

BTB is a real estate investment trust listed on the Toronto Stock Exchange. BTB is an important owner of properties in eastern Canada. Today, BTB owns 65 retail, office and industrial properties for a total leasable area to date of 5.2 million square feet. The objectives of BTB are: (i) to grow its revenues from its assets to increase distributable income and therefore fund distributions; (ii) to maximize the value of its assets through dynamic management of its properties in order to sustain the long-term value of its units; and (iii) to generate cash distributions that are fiscally beneficial to unitholders.

Read More: Rule of 72

Receive News & Ratings for BTB Real Estate Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTB Real Estate Investment Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Reaffirms Neutral Rating for IWG
JPMorgan Chase & Co. Reaffirms Neutral Rating for IWG
Howden Joinery Group  Price Target Raised to GBX 480
Howden Joinery Group Price Target Raised to GBX 480
JPMorgan Chase & Co. Reaffirms “Overweight” Rating for Restaurant Group
JPMorgan Chase & Co. Reaffirms “Overweight” Rating for Restaurant Group
Reviewing Blue Calypso  & Puxin
Reviewing Blue Calypso & Puxin
Wingstop  Hits New 52-Week High at $80.72
Wingstop Hits New 52-Week High at $80.72
$86.75 Million in Sales Expected for PTC Therapeutics, Inc.  This Quarter
$86.75 Million in Sales Expected for PTC Therapeutics, Inc. This Quarter


 
© 2006-2019 Zolmax.